Lv, Yinxiang <br/><br/>
Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.  [electronic resource] 

 -  Anti-cancer drugs  09 2017 
 - 861-868 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000527  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carrier Proteins--metabolism<br/>Cell Line, Tumor<br/>DNA-Binding Proteins--metabolism<br/>Dose-Response Relationship, Drug<br/>Down-Regulation--drug effects<br/>Doxorubicin--administration & dosage<br/>Drug Synergism<br/>Fluoresceins--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Nuclear Proteins--metabolism<br/>Signal Transduction--drug effects<br/>Tumor Suppressor Protein p53--genetics